Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Part D coverage gap and adherence to diabetes medications.

Gu Q, Zeng F, Patel BV, Tripoli LC.

Am J Manag Care. 2010;16(12):911-8.

2.
3.

Regional variation in use of a new class of antidiabetic medication among medicare beneficiaries: the case of incretin mimetics.

Marcum ZA, Driessen J, Thorpe CT, Donohue JM, Gellad WF.

Ann Pharmacother. 2015 Mar;49(3):285-92. doi: 10.1177/1060028014563951. Epub 2014 Dec 16.

4.

The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products.

Zhang Y, Lave JR, Donohue JM, Fischer MA, Chernew ME, Newhouse JP.

Med Care. 2010 May;48(5):409-17. doi: 10.1097/MLR.0b013e3181d68978.

PMID:
20393360
5.
6.

Hospital admission associated with Medicare Part D "doughnut hole".

Scott MA, Jackson VL, Hitch WJ.

Am J Health Syst Pharm. 2007 May 15;64(10):1029-30. No abstract available.

PMID:
17494900
7.

Quantifying the impact of drug exposure misclassification due to restrictive drug coverage in administrative databases: a simulation cohort study.

Gamble JM, McAlister FA, Johnson JA, Eurich DT.

Value Health. 2012 Jan;15(1):191-7. doi: 10.1016/j.jval.2011.08.005. Epub 2011 Oct 19.

8.

Cost-related nonadherence in the Medicare program: the impact of Part D.

Kennedy JJ, Maciejewski M, Liu D, Blodgett E.

Med Care. 2011 May;49(5):522-6. doi: 10.1097/MLR.0b013e318210443d.

PMID:
21430574
9.

Medication use and adherence among elderly Medicare beneficiaries with diabetes enrolled in Part D and retiree health plans.

Stuart B, Simoni-Wastila L, Yin X, Davidoff A, Zuckerman IH, Doshi J.

Med Care. 2011 May;49(5):511-5. doi: 10.1097/MLR.0b013e31820bf885. Erratum in: Med Care. 2011 Oct; 49(10):970.

PMID:
21422956
10.

Did Medicare Part D reduce disparities?

Zissimopoulos J, Joyce GF, Scarpati LM, Goldman DP.

Am J Manag Care. 2015 Feb;21(2):119-28.

11.

Cost sharing and decreased branded oral anti-diabetic medication adherence among elderly Part D Medicare beneficiaries.

Sacks NC, Burgess JF Jr, Cabral HJ, Pizer SD, McDonnell ME.

J Gen Intern Med. 2013 Jul;28(7):876-85. doi: 10.1007/s11606-013-2342-3. Epub 2013 Feb 13.

12.

Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: a retrospective cohort study.

Yang Y, Thumula V, Pace PF, Banahan BF 3rd, Wilkin NE, Lobb WB.

Clin Ther. 2009 Oct;31(10):2178-88; discussion 2150-1. doi: 10.1016/j.clinthera.2009.10.002.

PMID:
19922889
13.

The impact of health insurance coverage on pediatric diabetes management.

Wintergerst KA, Hinkle KM, Barnes CN, Omoruyi AO, Foster MB.

Diabetes Res Clin Pract. 2010 Oct;90(1):40-4. doi: 10.1016/j.diabres.2010.06.013. Epub 2010 Jul 13.

PMID:
20630611
14.

Impact of Part D low-income subsidies on medication patterns for Medicare beneficiaries with diabetes.

Stuart B, Yin X, Davidoff A, Simoni-Wastila L, Zuckerman I, Shoemaker JS, Doshi J.

Med Care. 2012 Nov;50(11):913-9. doi: 10.1097/MLR.0b013e31826c85f9.

PMID:
23047779
15.

Mail-order pharmacy use and medication adherence among Medicare Part D beneficiaries with diabetes.

Zhang L, Zakharyan A, Stockl KM, Harada AS, Curtis BS, Solow BK.

J Med Econ. 2011;14(5):562-7. doi: 10.3111/13696998.2011.598200. Epub 2011 Jul 6.

PMID:
21728913
16.

Effects of coverage gap reform on adherence to diabetes medications.

Zeng F, Patel BV, Brunetti L.

Am J Manag Care. 2013 Apr;19(4):308-16.

17.

Association of diet alone, insulin, sulfonylureas, metformin, and thiazolidinediones with the severity of coronary artery disease in patients with diabetes mellitus.

Ravipati G, Aronow WS, Ahn C, Sujata K, Saulle LN, Channamsetty V, Weiss MB.

Am J Ther. 2006 Sep-Oct;13(5):400-3.

PMID:
16988534
18.

Incretin enhancers and the evolution of antihyperglycemic therapy in type 2 diabetes.

Inzucchi SE.

Endocrinol Metab Clin North Am. 2007 Dec;36 Suppl 2 Incretin:2-17. Review. No abstract available.

PMID:
18405144
19.

Impact of cost sharing on prescription drugs used by Medicare beneficiaries.

Goedken AM, Urmie JM, Farris KB, Doucette WR.

Res Social Adm Pharm. 2010 Jun;6(2):100-9. doi: 10.1016/j.sapharm.2010.03.003. Epub 2010 May 7.

PMID:
20511109
20.

National assessment of Medicare prescription plan coverage gaps among patients with atrial fibrillation in the US.

Kim MH, Lin J, Kreilick C.

Adv Ther. 2009 Aug;26(8):784-94. doi: 10.1007/s12325-009-0054-1. Epub 2009 Aug 18.

PMID:
19690820

Supplemental Content

Support Center